- Home
- ORI vs ARWR Comparison
ORI vs ARWR Comparison
Compare ORI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORI | ARWR |
|---|---|---|
| Founded | 1923 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 9.4B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | ORI | ARWR |
|---|---|---|
| Price | $37.96 | $67.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | $42.50 | ★ $77.55 |
| AVG Volume (30 Days) | 1.7M | ★ 2.5M |
| Earning Date | 01-22-2026 | 02-05-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.15 | N/A |
| Revenue | ★ $9,136,200,000.00 | $829,448,000.00 |
| Revenue This Year | $5.36 | N/A |
| Revenue Next Year | $6.46 | N/A |
| P/E Ratio | $12.42 | ★ N/A |
| Revenue Growth | 10.99 | ★ 23258.15 |
| 52 Week Low | $34.43 | $9.57 |
| 52 Week High | $46.76 | $76.76 |
Technical Indicators
Market Signals| Indicator | ORI | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 24.10 | 54.99 |
| Support Level | $37.00 | $61.65 |
| Resistance Level | $43.65 | $68.24 |
| Average True Range (ATR) | 1.08 | 3.97 |
| MACD | -0.50 | -0.37 |
| Stochastic Oscillator | 13.19 | 42.57 |
Price Performance
Historical ComparisonAbout ORI Old Republic International Corporation
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.